Nuzenio

Oculis Reports

Oculis Reports news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 10 latest news signals 8 publisher sources 100/100 entity strength

Latest news

Oculis Holding AG reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Fri, 07 Aug 2026 01:55:00 GMTOculis Holding Reports Strong Equity Base and Updates SEC Risk Factors in Q2 2026 Filing - TipRanksTipRanks · Thu, 06 Aug 2026 21:28:36 GMTOculis reports Q2 EPS (16c), consensus (38c) - TipRanksTipRanks · Thu, 06 Aug 2026 20:53:45 GMTOculis (NASDAQ: OCS) pivots to neuro-ophthalmology as H1 loss falls - Stock TitanStock Titan · Thu, 06 Aug 2026 20:17:00 GMTOculis Reports Q2 2026 Financial Results and Provides Company Update - GlobeNewswireGlobeNewswire · Thu, 06 Aug 2026 20:05:00 GMTOculis Holding AG Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.commarketscreener.com · Thu, 06 Aug 2026 20:05:00 GMTOculis Announces Positive FDA Pre-IND Feedback Supporting Privosegtor Development Strategy for Treatment of Acute Multiple Sclerosis Relapses - Yahoo Finance UKYahoo Finance UK · Mon, 03 Aug 2026 08:00:00 GMTFDA Says Oculis Can Cross-Reference Data for Planned MS Relapse Trial - Stock TitanStock Titan · Mon, 03 Aug 2026 08:00:00 GMT

Timeline

Fri, 07 Aug 2026 01:55:00 GMTOculis Holding AG reports results for the quarter ended June 30 - Earnings Summary - TradingView
Thu, 06 Aug 2026 21:28:36 GMTOculis Holding Reports Strong Equity Base and Updates SEC Risk Factors in Q2 2026 Filing - TipRanks
Thu, 06 Aug 2026 20:53:45 GMTOculis reports Q2 EPS (16c), consensus (38c) - TipRanks
Thu, 06 Aug 2026 20:17:00 GMTOculis (NASDAQ: OCS) pivots to neuro-ophthalmology as H1 loss falls - Stock Titan
Thu, 06 Aug 2026 20:05:00 GMTOculis Reports Q2 2026 Financial Results and Provides Company Update - GlobeNewswire
Thu, 06 Aug 2026 20:05:00 GMTOculis Holding AG Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Oculis Reports.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

8 distinct publisher/source names are currently connected to this entity page.